
Common ground and differences in coverage across the media analysed.
The 2026 Nobel Prize in Chemistry is awarded to Henri Kagan (France) and Kenso Soai (Japan) for nonlinear effects and autocatalysis in asymmetric organic synthesis.
The perspectives link mirror molecules to the manufacture of medicines: the shape of a molecule can change the effect of a treatment, and thalidomide comes back as an example in several corpora.
Several corpora cite Heiner Linke, chairman of the Nobel Committee for Chemistry, who speaks of a solution to a chemical enigma over a century old.
Question: should this prize be viewed in light of 2001, when asymmetric catalysis was awarded without Henri Kagan? The Belgian, French, Italian, and Colombian corpora mention this and make it a key point; most others do not bring it up.
Question: how old is Kenso Soai? NPR writes 'Soai, 95 years old', while HuffPost, after correction, attributes 95 years to Kagan; the other corpora give Soai's age as 76.
Question: what element opens the narrative? Paris and Brussels place the late recognition for Kagan and national pride at the forefront, Tokyo focuses on Kenso Soai and the succession of Japanese laureates, while Washington, Ottawa, and Moscow start with the scientific enigma and medications.
This grouping describes the publications analysed, not the position of these countries’ populations or of their governments.
Preview: 3 of 18 media perspectives. Syntheses of the media analysed — not direct quotations. Method & limitations
Mexico City sees this Nobel Prize in Chemistry as the resolution of an ancient scientific enigma, that of mirror molecules, and above all retains the tool offered to chemists and the pharmaceutical industry.
4 sources · View sources
Lima takes note of the pharmaceutical aspect of the Nobel Prize in Chemistry: the Peruvian press presents Kagan and Soai's discovery as a tool for manufacturing medicines, with thalidomide as an example.
2 sources · View sources
The United States takes away from this Nobel a century-old chemical enigma, solved by reactions deemed "spectacular" and useful for the manufacture of medicines, in a dispatch tone.
2 sources · View sources
DOMINANT ANGLE
Mexico City sees this Nobel Prize in Chemistry as the resolution of an ancient scientific enigma, that of mirror molecules, and above all retains the tool offered to chemists and the pharmaceutical industry.
KEY POINTS
ANALYSIS
Mexico, October 8, 2026. The Mexican press reports on the 2026 Nobel Prize in Chemistry, awarded to Frenchman Henri Kagan and Japanese Kenso Soai. The Royal Swedish Academy of Sciences announced it on Wednesday, October 7, "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis," according to El Informador.
The Mexican account is primarily educational. Vanguardia and El Informador explain that certain molecules, such as amino acids, exist in two variants that are mirror images of each other, like a right hand and a left hand, while living beings only contain one of them. This property, homochirality, had long remained unexplained: when researchers triggered a reaction that could form both versions, they obtained equal quantities in their test tubes.
El Informador then details the contribution of each. Kagan took a decisive first step in 1986, finding a way to manipulate reactions that produce a greater excess than expected of one of the two forms. Vanguardia places Kagan at the University of Paris-Sud, in France, and Soai at the University of Science in Tokyo, Japan.
The Reforma dispatch, picked up by El Norte from Stockholm, gets to the point: the two laureates have solved a long-standing enigma, how to form a single mirror-image molecular form, which has "enormous importance" for the manufacture of pharmaceutical products. El Informador adds that, for molecules intended to interact with living organisms, such as medicines, only one of the two forms has the desired effect.
The coverage emphasizes practical usefulness over the individuals. According to El Informador, the work has given chemists new fundamental tools for their daily work. Vanguardia mentions applications in the design of molecules used, in particular, by the pharmaceutical industry. The articles consulted do not develop the age of the laureates, the political reaction in France or Japan, or the endowment of the prize.
DOMINANT ANGLE
Lima takes note of the pharmaceutical aspect of the Nobel Prize in Chemistry: the Peruvian press presents Kagan and Soai's discovery as a tool for manufacturing medicines, with thalidomide as an example.
KEY POINTS
ANALYSIS
Lima, October 8, 2026. The Peruvian press is treating the Nobel Prize in Chemistry as a scientific news item with concrete implications. Andina, the public agency, dated its dispatch from Stockholm on October 7: Frenchman Henri Kagan and Japanese Kenso Soai received the prize this Wednesday "for having solved one of the mysteries of life", namely why certain molecules in nature only appear in one form. Both media outlets, Andina and El Comercio, use the same formulation: an advance "fundamental for the development of medications".
The texts explain the principle using the image of hands. Certain molecules, known as chiral, exist in "right" or "left" versions depending on how they reflect light, with identical physical properties but very different biological effects. Almost all amino acids have two specular variants, but only one is found in the proteins of cells. This phenomenon, "homoquiralidad", was described by the Royal Swedish Academy of Sciences.
The Nobel Committee is quoted in a statement: their discoveries played "a decisive role for chemists who design reactions for the manufacture of pharmaceutical products". They allow for "triggering chemical reactions that lead to homochirality". Andina also reports the words of Heiner Linke, president of the committee: the two laureates have provided "a solution to a chemical mystery that dates back over a century", and their reactions are "spectacular".
DOMINANT ANGLE
The United States takes away from this Nobel a century-old chemical enigma, solved by reactions deemed "spectacular" and useful for the manufacture of medicines, in a dispatch tone.
KEY POINTS
ANALYSIS
Washington, October 8, 2026. The two articles from the American press pool, NPR and HuffPost World, picked up the Associated Press dispatch dated from Stockholm: Henri B. Kagan and Kenso Soai received the Nobel Prize in Chemistry on Wednesday, October 7, "for their discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis".
The account opens with a quote from Heiner Linke, chairman of the Nobel Committee for Chemistry: the two researchers have provided "a solution to a chemical enigma over a century old: how homochirality can emerge spontaneously". Linke adds that "the chemical reactions they developed are spectacular". The committee's statement, cited by NPR, specifies that this work has been "crucial for chemists designing reactions for the manufacture of pharmaceutical products". NPR also mentions the "Soai reaction", named after the experiment by the Japanese chemist.
The texts briefly situate the laureates: Kagan, born in France, is affiliated with the University of Paris-Sud in Orsay; Soai, born in Japan, with the University of Science in Tokyo. The HuffPost indicates that Kagan is 95 years old and notes that the article was corrected, the age having initially been attributed to Soai; the NPR version retains the attribution to Soai.
The rest of the coverage puts the prize in the calendar for the week. The Nobel Prize in Medicine was awarded on Monday, October 5, to three researchers whose work led to a tool that uses light to understand brain function; the Physics prize, on Tuesday, October 6, distinguished work on a rare group of neutrinos. Literature is expected on Thursday, October 8, Peace on Friday, October 9, and Economics the following Monday. The dispatches recall the 2025 laureate, molecular structures capable of trapping large quantities of gas, with leads for capturing greenhouse gases or harvesting desert humidity.
DOMINANT ANGLE
Ottawa is taking note of the 2026 Nobel Prize in Chemistry, particularly its medical implications: the Canadian press explains mirror molecules through the production of medications, leaving national pride aside.
KEY POINTS
ANALYSIS
Ottawa, October 8, 2026. The Nobel Prize in Chemistry was awarded on Wednesday to Frenchman Henri Kagan, 95, and Japanese Kenso Soai, born in 1950 in Hiroshima, "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis," reports CBC News. The award is worth 12 million Swedish crowns, or 1.7 million Canadian dollars, according to the public broadcaster.
Canadian media first highlight the image of the two hands. The Globe and Mail explains that some molecules exist in left and right versions, and that most medications require only one of the two forms. Global News details the example of carvone, whose reflection smells like mint and the other like caraway, and then the case of the medication: we want the version that cures the cold, not the one that aggravates the symptoms. The Toronto daily adds that this work also serves the flavor and perfume industries, where only one form is perceived.
The Nobel Committee provides the quotes repeated by the three media outlets. Heiner Linke, chairman of the chemistry committee, speaks of a "chemical enigma over a century old" regarding the spontaneous appearance of homochirality and judges the reactions developed as "spectacular," according to CBC. Peter Somfai, a member of the committee, describes Soai's experiment in Global News as "probably the coolest in organic chemistry." When asked about medications resulting from this work, he replies, "I would say all, because we use it as a tool."
DOMINANT ANGLE
Tokyo hails a Japanese Nobel laureate in chemistry, the second in a row, by placing Kenso Soai, a child of Hiroshima, at the centre of the story, before the enigma of mirror molecules.
KEY POINTS
ANALYSIS
Tokyo, October 8, 2026. Japan's press is hailing this Nobel Prize as a national victory. Kyodo leads with "Japan's researcher Soai": Kenso Soai, 76, an emeritus professor at the University of Tokyo's science department, born in Hiroshima, shares the chemistry prize with Frenchman Henri Kagan, 95, for "the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis," the Royal Swedish Academy of Sciences announced on Wednesday, October 7.
Kyodo highlights the continuity: this is the second consecutive year a Japanese researcher has won the chemistry prize, after Susumu Kitagawa, from Kyoto University, who won in 2025 along with two other researchers for porous materials capable of storing and releasing gases. The agency also describes the reaction on the ground: joy in Hiroshima and at the University of Tokyo, where students deem the news "unexpected." Soai, reached by phone during a press conference, says he is "very happy" to share the prize with Kagan; he was shopping when the Nobel committee called.
On the substance, the three media outlets explain the enigma of homochirality: certain molecules exist in two forms that are mirror images of each other, like hands, but living organisms use almost exclusively one of them. Heiner Linke, chairman of the committee, speaks of "a chemical enigma over a century old" and "spectacular" reactions. News On Japan devotes a lengthy educational article to chirality, from the Greek "hand," and presents Soai's reaction as proof that a tiny imbalance between left and right molecules can become an overwhelming preference for one form. The article mentions applications in pharmaceutical chemistry, perfumes, flavors, and advanced materials.
DOMINANT ANGLE
Buenos Aires is deciphering this Nobel Prize in Chemistry for its practical scope: from mirror molecules at the origin of life to more precise medications, with thalidomide as an example.
KEY POINTS
ANALYSIS
Buenos Aires, October 8, 2026. The Argentine press dedicates more explanatory work than national celebration to the 2026 Nobel Prize in Chemistry, awarded on Wednesday, October 7. Perfil and La Nación start with the same image: the right hand and the left hand, almost identical but not superimposable. Perfil transposes this to molecules, which exist "in two versions that are mirror images of each other", a difference "fundamental for the chemistry of living beings" and for manufacturing medicines, fragrances, and agrochemicals.
The Frenchman Henri Kagan and the Japanese Kenso Soai are distinguished by the Royal Swedish Academy of Sciences "for the discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis". Perfil specifies that the two laureates will share a prize of $1.2 million. The newspaper emphasizes the notion of chirality and the homochirality of living things: proteins are built with amino acids of a certain orientation, DNA with sugars of the opposite configuration. This preference has raised the question of its spontaneous appearance for over a century, while in the laboratory reactions produce the two forms in similar proportions.
La Nación headlines "the mystery that won the Nobel" and presents the two researchers as having solved "an enigma that puzzled chemists for over a century". Its angle is clearly health-related: a molecule can heal and its mirror image can harm. The most well-known case is thalidomide, effective against pregnancy nausea in one form, and causing birth defects in babies in the other. The newspaper adds the example of levodopa, used against Parkinson's disease, while dextrodopa is biologically inactive.
DOMINANT ANGLE
Canberra takes note of the practical aspect of the Nobel Prize in Chemistry: mirror molecules that, when properly chosen, separate the medicine that heals from the one that worsens the condition, using mint and caraway to illustrate.
KEY POINTS
ANALYSIS
Canberra, October 8, 2026. Australian media are treating the Nobel Prize in Chemistry, announced on Wednesday, October 7, as a story of hands. ABC News writes that Henri B. Kagan and Kenso Soai were awarded "for their discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis". The Frenchman is attached to the University Paris-Sud, in Orsay, the Japanese to the University of Science in Tokyo.
The story opens with the formula of the president of the Nobel Committee for Chemistry, Heiner Linke, cited by ABC: the two researchers have provided "a solution to a chemical enigma over a century old", namely how homochirality can emerge spontaneously. Linke adds: "The chemical reactions they developed are spectacular." PerthNow, which picks up a dispatch, quotes Peter Somfai, a member of the committee, for whom it is "probably the coolest experiment in organic chemistry".
To make the issue understandable, the two media use the same example. Many molecules in living things exist in two versions that resemble each other without being identical, like the right hand and the left hand. One form of carvone smells like mint, the other evokes caraway. In pharmacy, scientists want the version that heals a cold, not the one that would aggravate a runny nose. Kagan and Soai have found a way to make chemistry "choose a side".
DOMINANT ANGLE
Brussels notes the Nobel Prize in Chemistry's belated recognition of Henri Kagan, 95, whom the 2001 prize had overlooked despite his status as the "father" of asymmetric catalysis.
KEY POINTS
ANALYSIS
Brussels, October 8, 2026. The French-speaking Belgian press covers the Nobel Prize in Chemistry in the style of a news agency dispatch, published on Wednesday, October 7 at 12:05 p.m. and updated at 3:55 p.m. in La Libre Belgique, and at 12:15 p.m. and 3:56 p.m. in La Dernière Heure. The prize is awarded to Frenchman Henri Kagan and Japanese Kenso Soai "for their research in asymmetric catalysis".
The Nobel Committee is quoted first: "Their discoveries have played a crucial role for chemists who design reactions for the production of pharmaceutical products". The text does not detail the scientific mechanism of mirror molecules. It focuses on the industrial application, the production of pharmaceutical products.
The element that both headlines put at the center is the history of the prize. Part of the field had already been awarded in 2001, "but not Professor Kagan, considered in France and around the world as the 'father' of this technique". The articles recall that this omission had sparked protests from the French Ministry of Research at the time. The 2026 award is therefore seen in these columns as a recognition that comes twenty-five years later.
The two laureates are briefly presented. Henri Kagan, 95 years old, is currently a professor at the University of Paris-Saclay. Kenso Soai, 76 years old, is a professor at the University of Natural Sciences in Tokyo. Reached by phone by the Nobel Foundation, the latter reacted: "This is the most incredible day of my life".
DOMINANT ANGLE
Bogotá takes note of the 2026 Nobel Prize in Chemistry for its pharmaceutical scope: mirror molecules are presented as the key to the manufacture of medicines, more than as a laboratory enigma.
KEY POINTS
ANALYSIS
Bogotá, October 8, 2026. Colombian media outlets are covering the Nobel Prize in Chemistry awarded on Wednesday, October 7, to Frenchman Henri Kagan and Japanese national Kenso Soai, emphasizing the practical use of their work. Portafolio, an economic daily, headlines with "the key discovery to create medicines". El Colombiano opens with a "mystery of life": why, in nature, certain molecules only appear in one form.
The two newspapers quote the Nobel Committee's statement. The laureates are being rewarded for their research on non-linear effects and autocatalysis in asymmetric organic synthesis. According to the committee, their discoveries have played a crucial role for chemists designing reactions to manufacture pharmaceutical products.
The educational explanation uses the image of hands. So-called chiral molecules exist in two versions, "right" and "left", mirror images of each other. Almost all amino acids have two variants, but only one of them is found in cell proteins. The Royal Swedish Academy of Sciences calls this phenomenon "homochirality". El Colombiano specifies that these versions have identical physical properties but very different biological effects.
Both articles cite the committee's president, Heiner Linke: Kagan and Soai have provided the solution to a chemical mystery over a century old, namely how homochirality can arise spontaneously. Linke judges the reactions they developed as "spectacular".
DOMINANT ANGLE
Berlin sees this Nobel Prize in Chemistry as the solution to a century-old puzzle, explained by the image of the two hands and rooted in the memory of Contergan.
KEY POINTS
ANALYSIS
Berlin, October 8, 2026. On Wednesday, October 7, Tagesschau, Deutsche Welle, and FAZ reported on the awarding of the Nobel Prize in Chemistry to Frenchman Henri Kagan and Japanese Kenso Soai, announced by the Royal Swedish Academy of Sciences in Stockholm. The prize rewards the "discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis".
The German coverage is primarily educational. Tagesschau starts with the left and right hands: they resemble each other, but are mirror images, and choosing the wrong glove "pinches". The channel explains chirality, a word that literally means "hand character", and provides everyday examples: the main aroma of caraway, whose mirror image smells like mint. It also compares a molecule to a key and its lock: the inverted shape does not fit and can even damage the lock. A second Tagesschau article discusses the honor given to the "coolest experiment" in chemistry.
The topic is linked to health through Contergan. Tagesschau recalls the 1960s scandal: one form of the active ingredient, thalidomide, inhibits inflammation, while the other causes birth defects in the unborn child. The media emphasizes that many modern medications are designed as a single enantiomer, the other variant being ineffective or toxic, and thus avoided.
DOMINANT ANGLE
Helsinki interprets this Nobel Prize in Chemistry as a science lesson: the Finnish press explains the "right hand" and "left hand" of molecules and the century-old enigma that Kagan and Soai solved.
KEY POINTS
ANALYSIS
Helsinki, October 8, 2026. Finland's three media outlets, Helsingin Sanomat, YLE, and MTV Uutiset, report on the announcement made on Wednesday, October 7, by the Royal Swedish Academy of Sciences, of the Nobel Prize in Chemistry being awarded to Frenchman Henri Kagan and Japanese national Kenso Soai. None of them dwell on the nationalities or the laureates' backgrounds: the focus is on the phenomenon they studied.
MTV Uutiset provides the brief version. The prize rewards the resolution of the "asymmetric mystery of chemistry": certain molecules, including amino acids, exist in two forms that are mirror images of each other, and for a long time, it was unknown how such asymmetry could arise. The award ceremony will take place in Stockholm on December 10, with a prize of 12 million Swedish crowns, equivalent to slightly over one million euros.
YLE offers the longest explanation. The public broadcaster recalls that the term chirality comes from the Greek word cheir, "hand", and invites the reader to look at their own palms: mirror images of each other, but not superimposable. All known life is based on "left-handed" amino acids, a phenomenon called homochirality. According to YLE, Kagan and Soai have developed a process that produces large quantities of molecules with a single "hand" using auxiliary molecules that are much less pure than before.
DOMINANT ANGLE
Paris welcomes a Nobel that rectifies a "historical injustice": at 95 years old, Henri Kagan receives what was denied to him in 2001.
KEY POINTS
ANALYSIS
Paris, October 8, 2026. The 2026 Nobel Prize in Chemistry was awarded on Wednesday, October 7, to Frenchman Henri Kagan, 95, and Japanese Kenso Soai, 76, "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis," according to the announcement by the Royal Swedish Academy of Sciences. The sum of 12 million Swedish crowns, approximately 1.07 million euros, according to L'Express, is shared between the two laureates.
The French press begins by explaining the stakes. The chairman of the Nobel Committee for Chemistry, Heiner Linke, compared chiral molecules to hands: mirror images of each other, they do not overlap. Le Monde recalls the medical consequence with thalidomide, effective in its left-handed form and toxic in its right-handed form, withdrawn from the market in 1961 after the birth, according to the daily, of 10,000 to 20,000 malformed babies. The committee emphasizes that these discoveries have played "a decisive role for chemists who design reactions intended for the manufacture of pharmaceutical products."
But the French narrative focuses on 2001. That year, the Nobel Prize had crowned asymmetric catalysis without Henri Kagan, yet considered "in France and in the world" as the "father" of the technique. 20 Minutes, with AFP, attributes this exclusion to the rule of a maximum of three laureates and mentions a "wave of incomprehension"; the Ministry of Research had then protested. HuffPost France digs up the editorial by Didier Astruc in Le Monde, titled "The Nobel Prize in Chemistry stolen from Henri Kagan," and talks about "revenge."
DOMINANT ANGLE
Rome takes from the Nobel Prize in Chemistry the promise of safe medicines: the Italian press explains mirror molecules through thalidomide and recalls Kagan's exclusion in 2001.
KEY POINTS
ANALYSIS
Rome, October 8, 2026. The 2026 Nobel Prize in Chemistry was announced on Wednesday, October 7, in Stockholm by the Royal Swedish Academy of Sciences. It was awarded to Frenchman Henri B. Kagan and Japanese Kenso Soai "for the discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis," according to Libero Quotidiano. ANSA specifies that this announcement concludes "the tre giorni" dedicated to scientific Nobels.
The Italian press first focuses on explaining the enigma. ANSA, in its biotech section, headlines the "directors of mirror molecules" and quotes the president of the Nobel Committee for Chemistry, Heiner Linke: the two laureates have provided "a solution to a chemical mystery over a century old." Certain molecules exist in two variants, one a mirror image of the other, like hands; this phenomenon, chirality, is common in amino acids. According to the agency, Kagan and Soai were the first to control reactions on so-called "homochiral" molecules, paving the way for new technologies, especially for the production of medicines.
La Repubblica, under the pen of Elena Dusi, pushes the prism towards health. In living beings, only one of the two forms is "mysteriously" found, and medicines must respect this symmetry, "as the case of thalidomide teaches." The daily summarizes the contribution of the two researchers: they explained how to synthesize safe medicines.
DOMINANT ANGLE
Islamabad sees this Nobel as a matter of fundamental chemistry: a century-old enigma of mirror molecules, solved through reactions deemed "spectacular".
KEY POINTS
ANALYSIS
Islamabad, October 8, 2026. Pakistani media are treating the 2026 Nobel Prize in Chemistry as a pure science event, largely relaying it verbatim from Stockholm. Geo News headlines with the two researchers, "French, Japanese scientists share Nobel Prize in Chemistry," and recalls that the Royal Swedish Academy of Sciences confirmed the prize on Wednesday, October 7, 2026. Frenchman Henri Kagan, 95, emeritus professor at the University of Paris-Sud, and Japanese national Kenso Soai, born in Hiroshima, are sharing the award "for the discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis."
The narrative first focuses on explaining the phenomenon. Business Recorder extensively quotes Heiner Linke, chairman of the Nobel Committee for Chemistry: many molecules exist in two versions, mirror images of each other, "like my hands," which cannot be superimposed. These are called chiral, from the Greek word for "hand." Geo News reiterates Linke's formula that the two laureates have provided "a solution to a chemical enigma over a century old," and his judgment: "The chemical reactions they developed are spectacular."
The scientific chronology is given with precision. Kagan made the "first decisive step" in 1986, finding a way to conduct reactions that allowed for a greater excess of one of the two forms than previously thought possible. Soai built on this work to design the first reaction that could be homochiral, which he achieved in 2003. Geo News specifies that the Academy considers these discoveries "decisive for chemists who design reactions for the manufacture of medicines."
DOMINANT ANGLE
Moscow breaks down the Nobel Prize in Chemistry in simple terms: a mechanism of mirror molecules explained step by step, with pharmacy as an outlet, without any national stake.
KEY POINTS
ANALYSIS
Moscow, October 8, 2026. The Russian press treats the 2026 Nobel Prize in Chemistry as a scientific explanation, without a national angle. Kommersant headlines "Molecules deprived of reflection in the mirror" and specifies that the prize was awarded on Wednesday, October 7, to Frenchman Henri Kagan, from the University of Paris-Sud, and Japanese Kenso Soai, from the University of Tokyo's science department, for "the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis".
The daily explains that all amino acids exist in two mirror-image variants, while most living organisms contain only one: this is homochirality, from the Greek "same" and "hand". Until now, researchers obtained both variants in equal proportions in a test tube, which posed a problem in pharmacy, as only one of the two produces the desired effect. The laureates have enabled reactions "leading targetedly to homochirality". The newspaper quotes a statement evoking a "chemical enigma over a century old" and "simply stunning reactions". It presents these ideas, formulated at the end of the last century, as crucial for the production of new medicines.
Meduza emphasizes nuance: practical methods for separating isomers already existed. The laureates' contribution is to explain how an excess of one form can spontaneously arise in a reaction. In nature, this excess is almost exclusively found in compounds synthesized by enzymes: natural sugars are all right-handed (D), amino acids are left-handed (L). It was long considered impossible to obtain such an excess in ordinary reactions; when products can shift the equilibrium, autocatalysis favors an isomer.
DOMINANT ANGLE
Stockholm explains the chemistry of mirror hands: the Swedish press details the century-old enigma of homochirality and the scope of Kagan and Soai's "spectacular" reactions for drug manufacturing.
KEY POINTS
ANALYSIS
Stockholm, October 8, 2026. Svenska Dagbladet, DN, and The Local Sweden are focusing their coverage of the Nobel Prize in Chemistry on the science itself. The Royal Swedish Academy of Sciences announced on Wednesday, October 7, the award given to Henri Kagan, 95, emeritus professor at the University of Paris-Saclay, and to Kenso Soai, 76, from the University of Tokyo, "for the discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis".
The newspapers are following the Academy's pedagogy. Amino acids exist in two variants, mirror images of each other like human hands, but only one is found in the proteins of cells. SvD recalls that researchers have long been trying to obtain only one of the two forms, as in a medicine, only one has the desired effect. DN quotes Louis Pasteur, who was the first to observe these mirror images in crystallized tartaric acid in the 19th century. The Local uses the metaphor of the locksmith: two mirror-image keys come out of the workshop, but only one opens the lock, and the other can damage it.
The chronology is detailed by SvD: in 1986, Kagan discovered how to obtain an excess of one of the two forms greater than previously thought possible; in 1995, Soai designed the first reaction that could become homochiral; in 2003, he presented a reaction that forms only one of the two forms, explaining homochirality for the first time. According to the Academy, no one had achieved this through chemical means, except for life itself.
DOMINANT ANGLE
Dakar takes away from the 2026 Nobel Prize in Chemistry the scientific enigma: the Senegalese press explains the chirality of living things and the "spectacular reaction" of Kenso Soai, more than the national record.
KEY POINTS
ANALYSIS
Dakar, October 8, 2026. The Senegalese media are covering the 2026 Nobel Prize in Chemistry with educational dispatches, focusing more on the science than on the winners' countries of origin. PressAfrik and Senego report that Frenchman Henri Kagan and Japanese Kenso Soai were honored "this Wednesday, October 7" for "the discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis".
PressAfrik, which locates the Nobel Committee's announcement in Stockholm, opens with the stakes: this work provides "a fundamental answer to one of the greatest mysteries of science: the origin of the chirality of life". The site explains that the molecules of living organisms, such as DNA or amino acids, exist in only one "mirror" form, whereas chemistry naturally produces both.
The details of the contributions are given. In the 1980s, at the University of Paris-Sud, Henri Kagan showed that the purity of a catalyst is not proportional to the purity of the product obtained: a catalyst containing impurities or a mixture of both forms can still generate a highly purified product in one form. In the mid-1990s, according to the Nobel Committee, Kenso Soai designed a "spectacular chemical reaction", known as the Soai reaction, the first example where a chiral molecule acts as its own catalyst. From a tiny imbalance, the reaction "snowballs" to form only one form.
DOMINANT ANGLE
Taipei takes note of the implications of this Nobel Prize in Chemistry for pharmacy and the origin of life, with local researchers detailing the significance of "left" and "right" molecules.
KEY POINTS
ANALYSIS
Taipei, October 8, 2026. The Taipei Times and the Liberty Times are covering the Nobel Prize in Chemistry from the angle of its usefulness: what chirality changes for medicines, perfumes, and the understanding of living things.
The Taipei Times, which reprints a dispatch, explains that Henri Kagan, French, and Kenso Soai, Japanese, won the prize "on Wednesday" for having unraveled the enigma of mirror molecules, a discovery that served to develop "countless medications" and "transformed modern medicine". The newspaper illustrates the principle with carvone, one form of which smells like mint and the other like caraway, then recalls that DNA twists to the right and that human proteins are made up mainly of "left-handed" building blocks. It quotes Peter Somfai, a member of the Nobel Committee: "This is probably the coolest experiment in organic chemistry". The committee sees it as a feat never accomplished by anyone "other than life itself".
The Liberty Times, dated the same day, announces that the Royal Swedish Academy of Sciences designated the 95-year-old Frenchman and the 76-year-old Japanese on October 7 for nonlinear effects and autocatalysis in asymmetric organic synthesis. The daily newspaper solicited, via the Taiwan Science Media Center, several academics. Chen Jung-chieh, from Academia Sinica, distinguishes between left and right forms: left-handed limonene gives a pine scent, right-handed limonene gives a citrus scent. His colleague Hsieh Chun-chieh mentions pregnant women who took a medication for nausea and gave birth to malformed children: one form cured, the other caused the disease.
Explore every perspective on this subject across 18 countries.
Compare viewpoints and see where they diverge.
published on
countries
sources
articles
gap
The eighteen country corpora detail what the two reactions change for chemists, revisit the 2001 Nobel Prize, and open the narrative with different elements depending on the capitals: national laureate, medication, pedagogy, or calendar.
The prize has been awarded; the official Nobel Prize ceremony is scheduled to take place in Stockholm on December 10.
The Senegalese and Taiwanese presses are the ones that detail the mechanism. PressAfrik writes that, in the 1980s, Henri Kagan showed that the purity of a catalyst is not proportional to that of the product: an impure catalyst can give a product that is almost entirely of a single form.
« This is probably the coolest experience in organic chemistry »
The Liberty Times, which solicited academics via the Taiwanese Center for Science Media, reiterates this idea. According to its experts, the non-linear effect breaks this proportionality, and autocatalysis allows for obtaining a single form without a very pure catalyst, with significant savings for the industry and pharmacy.
Meduza adds nuance: practical methods for separating isomers already existed. The contribution of the laureates, the site writes, is to explain how an excess of one form can arise spontaneously in a reaction. On the Australian side, PerthNow quotes Peter Somfai, a member of the Nobel committee, who says it would be difficult to designate a specific medication developed in this way: these works serve as a tool and general understanding.
ANSA is the press that most clarifies this precedent. The Italian agency writes that in 2001 the prize was awarded to Americans Barry Sharpless and William Knowles and Japanese Ryoji Noyori for asymmetric catalysis. It recalls the letter addressed to the Nobel Foundation by the French Minister of Research at the time, Roger-Gérard Schwartzenberg, according to which Kagan had been the first to publish his discovery, in 1971.
« This rectifies a historical injustice »
In France, 20 Minutes, with AFP, links this exclusion to the rule of a maximum of three laureates and mentions a "wave of incomprehension". HuffPost France digs up a column by Didier Astruc in Le Monde, titled "The Nobel Prize in Chemistry stolen from Henri Kagan".
This reminder is included in the Belgian, French, Italian, Colombian, and Peruvian (Andina) corpora. This count measures what these articles choose to report, not the opinion of their readers. The American, Canadian, Japanese, Pakistani, and Swedish articles in the pool do not mention it.
Kyodo leads with Kenso Soai and Japan's continuity: this is the second consecutive year a Japanese national has won the chemistry prize, after Susumu Kitagawa in 2025. The agency also describes the joy in Hiroshima and the reactions of students, who deem the news "unexpected".
The German press starts with hands and gloves. Tagesschau recalls Contergan: one form of thalidomide inhibits inflammation, the other causes birth defects in the unborn child. In Finland, Helsingin Sanomat relies on Jan Deska, from the University of Helsinki: a drug from the wrong hand can be harmful.
In Buenos Aires, La Nación adds the example of levodopa, used against Parkinson's disease. These leads respond to different questions (who is awarded, why it matters, how it works) and do not contradict each other.
Several reports place the announcement within the week. NPR notes that the Nobel Prize in Medicine was awarded on Monday, October 5, to three researchers and the Physics prize on Tuesday, October 6. The FAZ names Germans Peter Hegemann and Georg Nagel, along with American Karl Deisseroth, for Medicine, and Francis Halzen for Physics. ABC News indicates that the Literature prize is expected on Thursday, October 8. DW reports a grant of one million crowns for the 125th anniversary of the Nobels.
A detail regarding age differs between two texts from the same dispatch. The NPR version writes "Soai, 95 years old", while HuffPost, after correction, attributes 95 years to Henri Kagan. The other reports give Kenso Soai's age as 76.
Kagan's affiliation is named in two ways: Paris-Saclay in Le Monde, Sud Ouest, Belgian and Swedish press, and Université Paris-Sud in the texts of Kommersant, Geo News, ABC News, and DW.
Amino acids and other molecules exist in two image forms of each other; living organisms only use one.
Medications, fragrances and perfumes; thalidomide, one form of which was toxic to the embryo, is the cited example.
The prize had rewarded asymmetric catalysis without Henri Kagan, which had sparked protests in France.
Emmanuel Macron hailed "an immense pride for the country" ; Kenso Soai mentioned "one of the most exciting days" of his life.
El Comercio illustrates the issue with thalidomide, an anti-nausea medication prescribed from 1956, effective in its left form and toxic in its right form. The text sees this as proof that molecular asymmetry can have enormous consequences.
Andina adds a reminder: studies related to this concept had already been awarded in 2001, but Professor Kagan, considered in France and elsewhere as the "father" of the technique, had not received the prize, which had sparked protests at the time. Peruvian coverage thus remains focused on chemistry and pharmacy, without a national angle or commentary from local researchers.
The award is 12 million Swedish crowns, approximately $1.2 million. The articles do not cite any reaction from Washington, nor comments from Paris or Tokyo, nor the context of thalidomide; the emphasis remains on the scientific nature of the enigma and its pharmaceutical outcome.
Regarding the winners' backgrounds, The Globe and Mail specifies that Kagan was born in 1930 in Boulogne-Billancourt, that he obtained his doctorate from the Collège de France in 1960, and that he received the Wolf Prize in Chemistry in 2001. He is among the oldest winners of the Chemistry Nobel. Global News summarizes the timeline: Kagan showed in the 1980s that it was possible to design reactions favoring one form, and Soai made this dream a reality years later.
The framing remains scientific and utilitarian. None of the three articles mention any political reaction, either Canadian or French, and the mention of affiliation with Paris-Saclay (Orsay) remains factual. CBC links the prize to the other two Nobels of the week, in medicine (optogenetics) and physics (neutrinos at the South Pole), through reading links.
The Mainichi, which reprints an AP dispatch, chooses a concrete image: carvone smells like mint in one form, caraway in the other; in pharmacy, one wants the version that treats the cold rather than the one that aggravates a runny nose. Peter Somfai, a committee member, describes the experiment as "probably the coolest in organic chemistry." The committee notes that Soai created the first reaction producing a single mirror image, something no one, except living organisms, had achieved.
Kagan's role, whose work in the 1980s showed that one could design reactions favoring one form, is presented as the precursor that Soai later concretized.
The human story is told through an anecdote: when asked where the Academy's call surprised him, Kenso Soai, born in Hiroshima in 1950, replies "I was shopping". An ordinary day that became, he says, the "most exciting of his life". Henri Kagan is presented as the 95-year-old Frenchman. The two articles do not mention, in the available passages, any French political reaction or debate about the fact that he was not selected in 2001.
For Argentine readers, the prize is thus presented as a key to understanding the pharmaceutical industry and perfumery, and as a partial answer to the question of the origin of life, more than as a prestigious event for France or Japan.
The articles detail the distribution of work. PerthNow explains that in the 1980s, Kagan's work showed that there could be a way to design reactions that produce one form rather than the other. Soai then "made this dream a reality" by creating the first reaction to produce only one of the mirror images. According to the committee, "apart from life itself, no one had achieved this feat before".
The medical dimension remains at the forefront. The committee's statement, cited by ABC, judges these researches "decisive for chemists who design reactions for the manufacture of pharmaceutical products". Somfai nuances, however: it would be difficult to say that a specific medicine has been developed in this way, as these works serve as a tool and general understanding. ABC also recalls the context of the announcements: the literature is expected on Thursday, peace on Friday, economics on Monday.
The articles also put the announcement into the Nobel season context. Chemistry is the third scientific prize, after medicine and physics, awarded on Monday and Tuesday. In 2025, the prize had distinguished new molecular structures capable of trapping gases. Before the announcement, experts were hesitating between very different fields, from gene therapy to sleep hormones, including self-assembled monolayers.
The Nobel Prize includes a diploma, a gold medal, and a check for 12 million Swedish crowns, or a little over one million euros. The economics prize will close the Nobel season on October 12.
No specific Belgian angle appears in these texts: neither a reaction from a Belgian researcher or university, nor a political commentary. The reading remains that of international news relayed with its historical context.
El Colombiano adds a historical element to the prize. Work in this field had already been awarded in 2001, but Kagan, considered in France and elsewhere as the "father" of the technique, had not been selected. The newspaper recalls that this absence had sparked protests at the time.
The coverage remains that of explanatory scientific information, without commentary on France's or Japan's place in the rankings. There is also no Colombian or Latin American reading: the national dimension is absent, and the narrative relies almost entirely on the Nobel Committee's statement and Linke's statements.
The committee is quoted by Tagesschau: its president, Heiner Linke, says that the two laureates have provided "a solution to a chemical puzzle over a century old: how homochirality can arise spontaneously". DW and FAZ associate Kagan with the University Paris-Sud and Soai with the Tokyo University of Science, and specify that their work has been crucial for chemists who lay the foundations for the production of medications. Tagesschau mentions that Kagan was born in 1930.
DW adds current events about the ceremony. The prize is worth twelve million Swedish crowns, approximately one million euros, after an increase of one million decided for the 125th anniversary of the Nobels. According to DW, this is the first time a woman has announced the laureates in physics, chemistry, and economics.
FAZ places the prize in Nobel week: Germans Peter Hegemann and Georg Nagel shared the Nobel Prize in Medicine with American Karl Deisseroth, and Belgian-American physicist Francis Halzen received the physics prize. Last year, the chemistry prize distinguished Susumu Kitagawa, Richard Robson, and Omar Yaghi for metal-organic structures. The literature, peace, and economics prizes will be announced in the following days.
Helsingin Sanomat highlights the practical implications, relying on Jan Deska, a professor of synthetic chemistry at the University of Helsinki. "Each amino acid in our body is left-handed," he says; only a molecule of the same "hand" matches, like a left-handed handshake only works with a left hand. A medication with the wrong "hand" can be harmful, and odors also differ: the turpentine of conifers is left-handed, while the right-handed form of the same molecule smells like lemon and orange. Deska adds that this work helps understand how chemical reactions led to life on Earth, which remains partly obscure.
The Finnish narrative thus remains scientific and didactic, without the dimension of national pride or the debate on the late recognition of a 95-year-old laureate that animates other presses. The only expert cited is a Finnish researcher, and the examples are those of everyday life: forest, citrus fruits, medications.
The voices from the scientific community go in the same direction. Jacques Maddaluno, emeritus researcher at CNRS, states: "This repairs a historical injustice." Emmanuelle Schulz, director of the Institute of Molecular Chemistry and Materials of Orsay, estimates that "French chemistry is very lucky." Sud Ouest and RFI specify that Kagan is a professor at the University of Paris-Saclay and has spent his entire career at Paris XI.
The national dimension is explicit. HuffPost counts the 75th French laureate and notes that this is the first French person distinguished this season. Emmanuel Macron mentioned "immense pride for the country" and wrote on X: "From Paris-Saclay to the Nobel, French science shines." Kenso Soai, reached by phone by the Nobel Foundation, said: "This is the most incredible day of my life." The economics prize will close the season on October 12.
A second thread of reading is the reminder of an old quarrel. ANSA headlines that the prize arrives "25 years after the controversy" over Kagan's exclusion. In 2001, the Nobel Prize had gone to Americans Barry Sharpless and William Knowles and Japanese Ryoji Noyori for asymmetric catalysis. The agency recalls the letter of protest sent to the Nobel Foundation by the French Minister of Research at the time, Roger-Gérard Schwartzenberg, who emphasized that Kagan had been the first to publish his discovery, in 1971. Kagan had chosen to remain absolutely silent. La Repubblica repeats the same reminder: he had been excluded from a Nobel Prize awarded for related research.
The treatment remains sober and pedagogical, without an Italian national angle: no political reaction or reaction from Italian research appears in the texts consulted. The articles focus on science, its pharmaceutical applications, and the late reparation made to a French chemist.
The amount of the prize, estimated at $1.2 million by Geo News, and the context of Nobel Week complete the picture. Business Recorder notes that chemistry is always the third award of the week, after medicine and physics, and mentions the physics prize awarded to Francis Halzen, a hunter of "ghost particles." The newspaper also recalls the 2025 Nobel Prize, awarded to Kitagawa, Robson, and Yaghi for metal-organic frameworks, useful in the face of climate change and freshwater scarcity.
The two articles contain neither an official Pakistani reaction nor a comparison with the state of national research, nor an angle on the age of the laureate or the missed Nobel Prize of 2001. The coverage remains that of an agency: facts, quotes from the committee, possible uses in pharmacy.
Meduza also puts the prize in the calendar: in 2025, chemistry had distinguished Richard Robson, Susumu Kitagawa, and Omar Yaghi for organometallic structures; literature will be announced on October 8, peace on October 9 in Oslo, and economics on October 12.
In the available excerpts, neither of the two texts dwells on the age of the laureates or French or Japanese national pride: the coverage remains didactic, focused on the chemical mechanism and its pharmaceutical use.
The president of the Nobel Committee for Chemistry, Heiner Linke, is quoted by the three titles: the two laureates "have provided a solution to a chemical enigma that is over a hundred years old", and their reactions are "spectacular". Thalidomide is used as an example: The Local and SvD mention the thousands of children born with malformations in the early 1960s, the Academy specifying that it was the mirror image of the active substance that caused the damage.
Kenso Soai, reached by phone during the press conference in Stockholm, spoke of "one of the most exciting days" of his life, and said he was happy to share the prize with Professor Kagan. The Local notes that he was shopping when the call from Stockholm arrived. DN emphasizes the usefulness of the work for new medicines and materials.
The Swedish coverage remains focused on the scientific content: it does not dwell on the reaction in Paris or Tokyo, nor on the age of the French laureate.
Senego, more brief, talks about "a Frenchman and a Japanese under the spotlight" and highlights the interest of these advances for organic chemistry and the development of substances used, in particular, in the pharmaceutical field. It specifies that the Royal Swedish Academy of Sciences designated the winners, that the prize is worth 12 million Swedish crowns, approximately one million euros, and that the official award ceremony is scheduled for December 10, the anniversary of Alfred Nobel's death.
Neither of the two texts comments on the national dimension of the prize or links it to Senegal or Africa: the reading is that of global scientific news, relayed for its content. Senego includes this announcement in the series opened after the medicine and physics prizes, announced at the beginning of the week.
The experts insist on the industrial scope. According to them, the nonlinear effect breaks the logic that the purity of the product follows that of the catalyst, and autocatalysis makes it possible to obtain a single form without a very pure catalyst, with significant savings in industry and pharmacy. Wu Yen-ku, from National Yang Ming Chiao Tung University, links the work to the enigma of L-type amino acids, a signature of terrestrial life. Wu Hsueh-liang, from National Taiwan Normal University, recalls that Soai came to Taiwan thirty years ago.
The Liberty Times also notes that this field, asymmetric organic synthesis, is being rewarded for the third time. Neither of the two newspapers dwells on the French or Japanese national dimension, nor on the age of the French laureate or his absence in 2001.
More divergent than 68% of recent comparable stories (reference: 90 recent stories measured with the same method).